APA (7th ed.) Citation

A, S., AT, A., AH, S. W., A, A. R., OM, E., MA, A., . . . MI, D. (2025). Impact of polypharmacy phenogroups on different heart failure phenotypes in patients with chronic heart failure: A retrospective examination of real-world cohort. Frontiers in pharmacology, 16, 1526112. https://doi.org/10.3389/fphar.2025.1526112

Chicago Style (17th ed.) Citation

A, Sukik, et al. "Impact of Polypharmacy Phenogroups on Different Heart Failure Phenotypes in Patients with Chronic Heart Failure: A Retrospective Examination of Real-world Cohort." Frontiers in Pharmacology 16 (2025): 1526112. https://doi.org/10.3389/fphar.2025.1526112.

MLA (9th ed.) Citation

A, Sukik, et al. "Impact of Polypharmacy Phenogroups on Different Heart Failure Phenotypes in Patients with Chronic Heart Failure: A Retrospective Examination of Real-world Cohort." Frontiers in Pharmacology, vol. 16, 2025, p. 1526112, https://doi.org/10.3389/fphar.2025.1526112.